Drugs that are administered directly to the middle and inner ear, as well as systemic therapies known to have ototoxic effects, require a specialized safety assessment plan and sophisticated testing capabilities. In this video, ototoxicology study director Dr. Rachel Tapp discusses ototoxicity study designs for drugs with ototoxic potential and how Charles River can support these preclinical studies. Discover our comprehensive auditory safety assessment services at [ Ссылка ]
For over 70 years, Charles River has provided essential products and services to help pharmaceutical and biotechnology companies, government agencies, and leading academic institutions around the globe, helping to accelerate their research and drug development efforts. With over 90 sites globally, we’re ready to tackle your product’s most unique challenges. Our focus on timeliness and accuracy in every stage of drug development means you can count on us to deliver reliable results – every step of the way.
Visit our website to learn more about our portfolio and how we can support your research. [ Ссылка ]
